1,520 Alzheimers Headlines
Patricio Reyes M.D., F.A.N.N.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

Barrow Neurological Institute
St. Joseph's Hospital and Medical Center
"2 NEW THERAPIES FOR ALZHEIMER'S"
Produced by MD Health Channel
Executive Editor.....Anne-Merete Robbs
CEO..............Stan Swartz

Dr. Reyes and his team are constantly working on new medicines and new solutions...You will receive news alerts...information on new trials as Dr Reyes announces them!
"2 NEW THERAPIES FOR ALZHEIMER'S"
Patricio Reyes M.D., F.A.N.N.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

St. Joseph's Hospital and Medical Center



DO YOU HAVE ALZHEIMERS?
 
"HELP DR. REYES... IN HIS BATTLE TO FIND A CURE...
.HE NEEDS YOUR HELP:
YOU CAN HELP WIN THE BATTLE FOR A CURE BY JOINING A TRIAL!!"....

Stan Swartz, CEO,
The MD Health Channel



"You'll receive all medication and study based procedures at
no charge

if you qualify for one of the many trials being conducted at Barrow Neurological Institute."
 

"Dr. Reyes Changed My Life"

- John Swartz
92 Years Old
Attorney at Law
"Dr.Reyes Changed My Life "
1:18
"At 92...I had lost my will to live"
5:48
Tips on Aging
2:29
"Dr. Reyes gave me customized health care"
2:09

Patricio Reyes M.D.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

Barrow Neurological Institute

St. Joseph's Hospital and Medical Center
"PRESERVING BRAIN FUNCTIONS "
Runtime: 50:22
Runtime: 50:22
"2 NEW THERAPIES FOR ALZHEIMER'S"
Runtime: 10:27
Runtime: 10:27
ALZHEIMER'S AWARENESS PROGRAMS
Runtime: 5:00
Runtime: 5:00
BIOMEDICAL RESEARCH IN ALZHEIMER'S DISEASE
PDF Document 850 kb

Download Free

4 TALES OF NEUROSURGERY &
A PIANO CONCERT BY DR. SPETZLER...
Plus 2 books written by Survivors for Survivors!
Robert F. Spetzler M.D.
Director, Barrow Neurological Institute

J.N. Harber Chairman of Neurological Surgery

Professor Section of Neurosurgery
University of Arizona
TALES OF NEUROSURGERY:
A pregnant mother..a baby..faith of a husband.. .plus... Cardiac Standstill: cooling the patient to 15 degrees Centigrade!
Lou Grubb Anurism
The young Heros - kids who are confronted with significant medical problems!
2 Patients...confronted with enormous decisions before their surgery...wrote these books to help others!
A 1 MINUTE PIANO CONCERT BY DR. SPETZLER

Michele M. Grigaitis MS, NP
Alzheimer's Disease and Cognitive Disorders Clinic

Barrow Neurological Clinics
COPING WITH DEMENTIA
 
Free Windows Media Player Click

Links
Barrow Neurological Institute

Archives
October 2006  
November 2006  
December 2006  
January 2007  
February 2007  
March 2007  
May 2007  
June 2007  
November 2007  
December 2007  
April 2008  
July 2008  
August 2008  
September 2008  
October 2008  
November 2008  
December 2008  
January 2009  
February 2009  
March 2009  
April 2009  
May 2009  
February 2010  
March 2013  
May 2013  
November 2013  
January 2014  
February 2014  
March 2014  
April 2014  
May 2014  
June 2014  
July 2014  
June 2016  
July 2016  
August 2016  
September 2016  
October 2016  
November 2016  
December 2016  
January 2017  
February 2017  
March 2017  
April 2017  
May 2017  
June 2017  
July 2017  
August 2017  
September 2017  
October 2017  
November 2017  
December 2017  
January 2018  
February 2018  
March 2018  
April 2018  
May 2018  
June 2018  
July 2018  
August 2018  
September 2018  
October 2018  
November 2018  
December 2018  
January 2019  
February 2019  
March 2019  
April 2019  
May 2019  
June 2019  
July 2019  
August 2019  
September 2019  
October 2019  
November 2019  
December 2019  
January 2020  
February 2020  
March 2020  
April 2020  
May 2020  
June 2020  
July 2020  
August 2020  
September 2020  
October 2020  
November 2020  
December 2020  
January 2021  
February 2021  
March 2021  
April 2021  
May 2021  
June 2021  
July 2021  
August 2021  
September 2021  
October 2021  
November 2021  
December 2021  
January 2022  
February 2022  
March 2022  
April 2022  
May 2022  
June 2022  
July 2022  
August 2022  
September 2022  
October 2022  
November 2022  
December 2022  
January 2023  
February 2023  
March 2023  
April 2023  
May 2023  
June 2023  
July 2023  
August 2023  
September 2023  
October 2023  
November 2023  
December 2023  
January 2024  
February 2024  
March 2024  

This page is powered by Blogger. Isn't yours?

Thursday, September 22, 2016

 

Why does Alzheimer’s disease affect more women than men?



























Supported by a new grant from the Alzheimer’s Association, USC researcher explores a key Alzheimer’s gene and how it disproportionately impacts women

Among the 5 million Americans diagnosed with Alzheimer’s disease, nearly two-thirds are women.
While the reason for this striking discrepancy isn’t yet known, proposed theories range from differences in health care usage and lifestyle factors to life span and other biological variations. USC Leonard Davis School of Gerontology Professor Christian Pike studies this disparity at the deepest level, examining key genes involved in Alzheimer’s and how their effects differ in males and females.

“Men and women are affected by Alzheimer’s disease differently, both in terms of disease development and progression,” he said. “Understanding the underlying bases of these differences should be useful in determining whether we need to view prevention and treatment differently depending upon gender.”

New project
Pike’s newest project will specifically examine the gene for apolipoprotein E-4 (APOE4), a primary genetic risk factor for Alzheimer’s. The presence of the APOE4 gene disproportionately increases the risk for the disease in women versus men, Pike said.

“In women, Alzheimer’s disease risk is increased approximately four times with one copy of the gene and 10 times with two copies of the APOE4 gene, whereas men show essentially no increased risk with one APOE4 gene and only a fourfold increase in risk with two copies of APOE4,” he said. “Even in the absence of dementia, APOE4 is associated with significantly increased atrophy and dysfunction of the brain and that affects women much more strongly than men.”

One of the ways APOE4 affects Alzheimer’s risk is by increasing inflammation in the brain, and several other genetic risk factors for the disease also affect the functioning of the immune system, Pike explained. His team’s earlier experiments with USC University Professor Caleb Finch — conducted with mice genetically engineered to have the APOE4 gene and develop a disease akin to human Alzheimer’s — showed that females with the gene developed worse signs and symptoms of the illness as well as more neuroinflammation compared to males with APOE4.

It raises the question of how feminine characteristics of the brain affect APOE4, which Pike and his team will explore using mice designed to have the gene as well as varying levels of female brain traits.

“Sex is a spectrum of maleness to femaleness, a spectrum that can be manipulated in early life by exposure to hormones,” Pike said. “By manipulating sexual differentiation, we will test whether increased femininity of the brain increases the Alzheimer’s-associated effects of APOE4.”

In addition, the project will explore whether an anti-inflammatory drug can interrupt the cellular signals that enable APOE4’s harmful effects. However, the answer to Alzheimer’s likely isn’t as simple as just decreasing the amount of neuroinflammation, Pike added.

“Interestingly, a certain amount of inflammation may be beneficial in combating Alzheimer’s,” he said. “Thus, it is important to understand what aspects of inflammation are harmful and which are useful so that we can develop therapeutic interventions that optimally regulate these processes.”

Sex and gender research
The new study is supported by a $250,000 Sex and Gender in Alzheimer’s (SAGA) research grant from the Alzheimer’s Association. The organization announced the first-ever SAGA grants, which aim to accelerate research on sex differences in Alzheimer’s disease, on Aug. 30.

Pike is one of only nine investigators in the world named as SAGA grant recipients. In a nod to USC’s strength in Alzheimer’s research, he is one of two recipients from USC: Keck School of Medicine Professor Terrence Town will study how sex differences in brain structure and hormonal changes during aging interact to affect the development of Alzheimer’s and whether estrogen treatment can help prevent these changes in Alzheimer’s-like rats.

SAGA is a core component of the Alzheimer’s Association Women’s Initiative. The broader initiative highlights the multiple and disproportionate effects of Alzheimer’s on women as caregivers, advocates and people living with the disease. It launched in June 2014 with a major goal of engaging more women in the fight against Alzheimer’s, according to a press release issued by the organization.

“Research showed us how women experience heart disease differently from men. We need to look at Alzheimer’s in a similar way. If we can better understand the disease processes and progression in men and women, we have an opportunity to tailor how we approach detection, diagnosis and therapeutic approaches based on sex,” said Maria Carrillo, Alzheimer’s Association chief science officer. “As a core part of this discussion, we must explore fundamental differences in biological characteristics and lifestyle factors between the sexes that may play a role to the disproportionate impact on women.”

Story Source: The above story is based on materials provided by USCNEWS
Note: Materials may be edited for content and length